Position in IMVT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$49,080,585
-$1,146,004 QoQ
Shares Held
1,975,869
0.0% QoQ
Ownership
0.962%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMVT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Woodline Partners LP holds $3,316,203,980 across 189 Biotechnology names. IMVT ranks #19 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,506,570 | $243,763,932 | |
| 2 | TNGX |
Tango Therapeutics, Inc.
|
8,000,013 | $167,360,271 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $149,053,834 | |
| 4 | RCUS |
Arcus Biosciences, Inc.
|
3,777,798 | $81,600,436 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
243,883 | $80,693,568 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
1,500,470 | $73,763,105 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
758,891 | $66,000,750 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,000,428 | $65,938,209 |
All Filings in IMVT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $49,080,585 | 1,975,869 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $50,226,589 | 1,975,869 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $24,159,447 | 1,498,725 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $23,979,600 | 1,498,725 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $25,598,581 | 1,497,869 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $15,920,323 | 642,726 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $40,340,994 | 1,414,977 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $48,138,156 | 1,823,415 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $41,663,874 | 1,289,504 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $31,608,706 | 750,266 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $37,011,146 | 964,083 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $12,047,676 | 635,091 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,134,051 | 137,592 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $14,501,022 | 816,959 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $9,844,738 | 1,764,290 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $359,190 | 92,100 | Shares | Sole | 2022-08-15 | |
| 2021-09-30 | $2,099,495 | 241,599 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $39,643,577 | 3,750,575 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $14,381,736 | 896,617 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $13,944,899 | 301,903 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,967,772 | 141,170 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $5,622,609 | 230,908 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $5,061,473 | 325,183 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||